DrazCanna, Inc.
DZCAOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$129345
P/E Ratio—
52W High$0.013
52W Low$0.0001
DrazCanna, Inc. (DZCA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DZCA · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2016Report Date: Mar 31, 2016EPS Actual
-$0.19
Revenue
$0.00B
Fiscal Period
Q1 FY2016
FY ends December
Report Date
Mar 31, 2016
After Market Close
DZCA reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2016 | Mar 31, 2016 | — | -$0.19 | — | $0.00B | — | — |
| — Q4 FY2015 | Dec 31, 2015 | — | -$0.14 | — | $0.00B | — | — |
| — Q3 FY2015 | Sep 30, 2015 | — | -$0.14 | — | $0.00B | — | — |
| — Q2 FY2015 | Jun 30, 2015 | — | -$0.49 | — | $0.00B | — | — |
| — Q1 FY2015 | Mar 31, 2015 | — | -$0.86 | — | $0.00B | — | — |
| — Q4 FY2014 | Dec 31, 2014 | — | -$0.53 | — | $0.00B | — | — |
| — Q3 FY2014 | Sep 30, 2014 | — | -$0.83 | — | $0.00B | — | — |
| — Q1 FY2014 | Mar 31, 2014 | — | -$0.42 | — | — | — | — |
Q1 FY2016
Mar 31, 2016
EPS Actual
-$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2015
Dec 31, 2015
EPS Actual
-$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2015
Sep 30, 2015
EPS Actual
-$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2015
Jun 30, 2015
EPS Actual
-$0.49
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2015
Mar 31, 2015
EPS Actual
-$0.86
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2014
Dec 31, 2014
EPS Actual
-$0.53
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2014
Sep 30, 2014
EPS Actual
-$0.83
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2014
Mar 31, 2014
EPS Actual
-$0.42
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2016 | Mar 31, 2016 | — | $0.00 | $0.00 | +0.00% |
| — Q4 FY2015 | Dec 31, 2015 | — | $0.00 | $0.00 | +107.69% |
| — Q3 FY2015 | Sep 30, 2015 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2015 | Jun 30, 2015 | — | $0.00 | $0.00 | +0.00% |
| — Q1 FY2015 | Mar 31, 2015 | — | $0.00 | $0.00 | +25.00% |
| — Q4 FY2014 | Dec 31, 2014 | — | $0.00 | $0.00 | +7.69% |
| — Q3 FY2014 | Sep 30, 2014 | — | $0.00 | $0.00 | +0.00% |
| — Q1 FY2014 | Mar 31, 2014 | — | $0.00 | $0.00 | +0.00% |
Q1 FY2016+0.00%
Report Date
Mar 31, 2016
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2015+107.69%
Report Date
Dec 31, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2015+0.00%
Report Date
Sep 30, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2015+0.00%
Report Date
Jun 30, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q1 FY2015+25.00%
Report Date
Mar 31, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2014+7.69%
Report Date
Dec 31, 2014
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2014+0.00%
Report Date
Sep 30, 2014
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q1 FY2014+0.00%
Report Date
Mar 31, 2014
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Beat Rate0 / 8 quarters
Largest Move+107.69% (Q4 FY2015)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DZCA ends December
DrazCanna, Inc. (DZCA) most recently reported earnings on March 31, 2016 for Q1 FY2016, posting EPS of $-0.19 (in line with the analyst consensus of —). The next DZCA earnings date is expected around September 1, 2026.
Each quarter, investors track DZCA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DZCA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DZCA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DZCA earnings · 4 questionsDrazCanna, Inc.'s next earnings report is expected around September 1, 2026. DZCA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DZCA historically reports after market close (AMC).
DZCA earnings datewhen is DZCA earningsDZCA next earnings datewhen does DZCA report earningsDZCA earnings calendar
▸ Source: FMP · DrazCanna, Inc. SEC filings · US GAAP · DrazCanna, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026